Chapter 1. DNA VACCINES MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. DNA VACCINES MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. DNA VACCINES MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. DNA VACCINES MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. DNA VACCINES MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. DNA VACCINES MARKET– By Type

6.1. DNA Vaccines for Humans

6.2. DNA Vaccines for Animals

Chapter 7. DNA VACCINES MARKET– By Technology

7.1. Plasmid DNA Vaccines Technology

       7.1.1. Therapeutic Technology

       7.1.2. Preventive Technology

7.2. Plasmid DNA Delivery Technology

       7.2.1. Uncomplexed Plasmid DNA

       7.2.2. Liposomes

       7.2.3. Gold Particles

       7.2.4. Others

Chapter 8. DNA VACCINES MARKET– By Application

8.1. Human Diseases

       8.1.1. Oncology

              8.1.1.1. Pancreatic Cancer

     8.1.1.2. Breast Cancer

      8.1.1.3. Ovarian Cancer

      8.1.1.4. Others

       8.1.2. Infectious Diseases

              8.1.2.1. Cytomegalovirus (CMV)

      8.1.2.2. Hepatitis B (HBV)

      8.1.2.3. Others

       8.1.3. Allergies

       8.1.4. Others

8.2. Veterinary Disease

       8.2.1. Canine Melanoma

       8.2.2. Leishmaniasis

       8.2.3. Others

Chapter 9. DNA VACCINES MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. DNA VACCINES MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10